ArticleJournal of the advanced practitioner in oncology2023

Characterization and Management of Adverse Reactions in Patients With Unresectable Hepatocellular Carcinoma Treated With Lenvatinib.

Anna Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.